AI assistant
Pfizer Ltd. — Board/Management Information 2024
Nov 14, 2024
60507_rns_2024-11-14_c1c14e2b-9e4e-4877-b17e-4fa5dd0119ee.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [100 x 42] intentionally omitted <==
Pfizer Limited
The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274
November 14, 2024
The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER
Dear Sirs,
Sub: Intimation regarding appointment of Legal Lead (Senior Management Personnel) of the Company.
Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘SEBI Listing Regulations’), we hereby inform that the Board of Directors of the Company, upon recommendation of the Nomination and Remuneration Committee has appointed Mr. Chetan Solse as India Legal Lead of the Company effective November 18, 2024. Accordingly, Mr. Chetan Solse shall be a Senior Management Personnel of the Company effective the said date.
Additional details required to be disclosed pursuant to the SEBI Listing Regulations 2015 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are enclosed as Annexure A.
Request you to please take the above on record.
Thanking you,
Yours truly,
For Pfizer Limited PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2024.11.14 18:28:49 +05'30' Prajeet Nair
Director – Corporate Services & Company Secretary
CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in
Annexure A
| Sr. no |
Particulars | Particulars | Details |
|---|---|---|---|
| 1. | Name | Mr. Chetan Solse | |
| 2. | Reasons for change | Appointment of Mr. Chetan Solse as India Legal Lead of the Company effective November 18, 2024. Accordingly, Mr. Chetan Solse shall be a Senior Management Personnel of the Company effective the said date. |
|
| 3. | Date of Appointment | ~~and Term~~ | November 18, 2024 |
| 4. | Affirmation as per List/Comp/14/2018- 19 dated June 20, 2018 |
Not Applicable | |
| 5. | Relationship inter-se Directors / Key Managerial Personnel / Senior Management Personnel |
Mr. Chetan Solse is not related to any of the Directors / Key Managerial Personnel / Senior Management Personnel. |
|
| 6. | Number of Shares held in the Company | Nil | |
| 7. | Brief Profile | Mr. Solse holds a Bachelor’s Degree in Commerce and Law from the University of Mumbai and is a certified member of the Institute of Company Secretaries of India (ICSI) and the Institute of Chartered Secretaries and Administrators (ICSA), UK. Mr. Solse is an accomplished legal counsel with over two decades of expertise in corporate legal advisory, litigation management, ethics & compliance, and risk management particularly within the healthcare and FMCG sectors. Mr. Solse joins the Company from Roche Diagnostics India Private Limited where he served as Head Legal & Risk Management (India & Neighboring Markets). Prior to his role with Roche Diagnostics India Private Limited, Mr. Solse has held senior positions at Parle Agro Private Limited, Diageo India Private Limited and Edwards Life Sciences (India) Private Limited. |